GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Hanmi Science Co Ltd (XKRX:008930) » Definitions » Price-to-Owner-Earnings

Hanmi Science Co (XKRX:008930) Price-to-Owner-Earnings : 20.77 (As of May. 06, 2024)


View and export this data going back to 1988. Start your Free Trial

What is Hanmi Science Co Price-to-Owner-Earnings?

As of today (2024-05-06), Hanmi Science Co's share price is ₩33550.00. Hanmi Science Co's Owner Earnings per Share (TTM) ended in Dec. 2023 was ₩1615.39. It's Price-to-Owner-Earnings for today is 20.77.


The historical rank and industry rank for Hanmi Science Co's Price-to-Owner-Earnings or its related term are showing as below:

XKRX:008930' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 15.01   Med: 119.73   Max: 9472.75
Current: 20.77

During the past 13 years, the highest Price-to-Owner-Earnings of Hanmi Science Co was 9472.75. The lowest was 15.01. And the median was 119.73.


XKRX:008930's Price-to-Owner-Earnings is ranked worse than
61.7% of 47 companies
in the Medical Distribution industry
Industry Median: 13.84 vs XKRX:008930: 20.77

As of today (2024-05-06), Hanmi Science Co's share price is ₩33550.00. Hanmi Science Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₩1,694.00. Therefore, Hanmi Science Co's PE Ratio for today is 19.81.

As of today (2024-05-06), Hanmi Science Co's share price is ₩33550.00. Hanmi Science Co's EPS without NRI for the trailing twelve months (TTM) ended in was ₩1,717.88. Therefore, Hanmi Science Co's PE Ratio without NRI for today is 19.53.

During the past 13 years, Hanmi Science Co's highest PE Ratio without NRI was 2625.34. The lowest was 18.10. And the median was 69.20.


Hanmi Science Co Price-to-Owner-Earnings Historical Data

The historical data trend for Hanmi Science Co's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hanmi Science Co Price-to-Owner-Earnings Chart

Hanmi Science Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 91.29 346.61 115.41 38.69 24.27

Hanmi Science Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.69 37.68 29.71 22.24 24.27

Competitive Comparison of Hanmi Science Co's Price-to-Owner-Earnings

For the Medical Distribution subindustry, Hanmi Science Co's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hanmi Science Co's Price-to-Owner-Earnings Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Hanmi Science Co's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Hanmi Science Co's Price-to-Owner-Earnings falls into.



Hanmi Science Co Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Hanmi Science Co's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=33550.00/1615.39
=20.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hanmi Science Co  (XKRX:008930) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Hanmi Science Co Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Hanmi Science Co's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Hanmi Science Co (XKRX:008930) Business Description

Traded in Other Exchanges
N/A
Address
214 Muha-ro Paltan-myeon, Gyeonggi-do, Hwaseong, KOR
Hanmi Science Co Ltd is a Korea-based holding company. The company through its subsidiaries manufactures and distributes pharmaceutical products. The company offers prescription drugs such as neuropathic pain, obesity, epilepsy, lactobacillus intestinal supplement, oral care, hair growth, anti-inflammatory, schizophrenia, smoking cessation aid, diabetes, osteoporosis, antiemetic, vaginal contraceptive, expectorants, ophthalmic, immunosuppressant, prostatism, cancer, antitussives, vitamins and nutritional supplements, constipation, dermatology, among others.

Hanmi Science Co (XKRX:008930) Headlines

No Headlines